World-Class Retina Care. Community-Based Caring.

Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event

Posted On October 19, 2021 / By / Posted in Blog

Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event

On October 24, 2021, Texas Retina Associates’ Ashkan M. Abbey, MD, will serve on a distinguished panel of presenters from across the country for a Retina World Congress continuing medical education (CME)

read more
Posted On March 3, 2021 / By / Posted in Blog

What is an Amsler Grid?

An Amsler grid is a tool that can help detect early signs of retinal disease that affect the macula which is the center of vision in the retina. Age-related macular degeneration (AMD)

read more
Posted On February 5, 2021 / By / Posted in Blog

February is AMD/Low Vision Awareness Month

By Ivan G. Castillo, MD February is national age-related macular degeneration (AMD) and low vision awareness month.  Low vision is a visual impairment that cannot be corrected by standard eyeglasses, contact lenses, medication

read more
Posted On September 3, 2019 / By / Posted in Blog

Ashkan Abbey, MD, Publishes Article on Key Retina Research Findings Presented at ARVO Meeting

Texas Retina Associates’ Ashkan Abbey, MD, serves on the editorial board of Retina Specialist, a medical journal focused on the latest advances in the diagnosis, medical management and surgical treatment of diseases

read more
Posted On January 15, 2019 / By / Posted in Blog

When Should You See a Retina Specialist

Your ophthalmologist or optometrist can monitor your vision, prescribe glasses and contact lenses, and diagnose, treat and prevent a number of eye diseases. However, for some eye conditions, your eye doctor may

read more
Posted On July 29, 2015 / By / Posted in Blog

Rand Spencer, MD, Performs Stem Cell Transplant for First Patient in Phase II Clinical Trial for Dry Age-Related Macular Degeneration

Texas Retina Associates’ Rand Spencer, MD, recently performed transplant surgery for the first participant in the Radiant Study, which is a Phase II clinical trial to evaluate the safety and efficacy of

read more